WILMINGTON – Prelude Therapeutics is one of Delaware’s burgeoning life science success stories, and it recently announced a new milestone in signing its first partnership agreement with a major Canadian […]
The portfolio companies of The Innovation Space recently eclipsed $1 billion in funding as the not-for-profit prepares for new tenants.
MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
Prelude Therapeutics announced Thursday that it’s selling millions of new shares to raise $100 million to support its drug pipeline research.
The first Delaware DNA conference hosted by the Delaware BioScience Association drew about 350 people to network and listen to panels.
© 2023 Delaware Business Times
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.